Avidex and ChemOvation Agreement
- Athersys Expands Partnership with BMS
- Milestone Reached in Biotage FLASH Sales
- Versicor and Biosearch to Merge
- Amgen Completes Acquisition of Immunex
Stories and more...
European Computational Chemistry Conference (EUCO-CC4)
1 - 6 September, Assisi,
The Fourth European Conference on Computational Chemistry will deal with
the main aspects of computational chemistry for academia and industry.
The focal points of the conference will cover theory and method separately
from technology and applications in the following four areas; High level
ab initio treatments on small molecules and elementary processes; Models
and simulations for complex systems; Approximate methods for large molecules;
Statistical treatments and chemical education.
in organic and combinatorial chemistry
14 - 21 September, Novgorod the Great, Russia
is no longer simply a synthetic technique but more and more is driving
technology. The Second Eurasian Meeting on Heterocyclic Chemistry brings
together speakers from across Europe, the Middle East and Asia to discuss
the challenges facing todays synthetic chemists and to help foster contactand
cooperation across the Eurasian continent.
Chemistry: Conventional Tools from Revolutionary Technology
22 - 25 September, Leesburg, VA
The third ACS Prospectives
conference on Combinatorial Chemistry will address how combichem technologies
are being applied and how the latest discoveries can be used to increase
productivity. The conference will take a practical approach to the subject,
presenting techniques that can be applied in real life, while also presenting
the latest cutting-edge discoveries from the leading scientists in the
8th Annual Conference and Exhibition
September 22-26, The Hague, The Netherlands
- Post-Genomic Target Identification & Pharmacogenomics
- Machine Intelligence in Informatics
- Novel Detection Technologies
- Trends in Automation, Miniaturization & Nanotechnology
- Novel Screening Methods with High Information Content
- High Throughput Chemistry - What Works Where
- Screening & IP Issues
- Metabolically Engineered Cells & Organisms
- Imaging Technologies
Ion Channel Assays in the Drug Discovery Process,
Ion channels play an important role in numerous cell types and occur as
large families of related genes with cell-specific statement patterns.
A new report addresses the need for a comprehensive study within the field.
It identifies 23 companies with a strong focus in this area, considers
the available and future possibilities in ion channel assays, an outlook
at the competitive landscape of companies in this field, and guides the
user to technologies that suit different segments of the drug discovery
Priced from $2,550 more information
can be view on our online Catalog
GPCRs: The Targets of Today's
Drugs and Tomorrow's Blockbusters, June 2002
G Protein-Coupled Receptors (GPCRs) have proven to be a highly amenable
target class to successful therapeutic intervention. Of the approximate
500 drugs currently marketed, more than 30% are modulators of GPCR function.
By 2000, 26 of the top 100 pharmaceutical products were compounds that
target GPCRs, accounting for sales of over $23.5 billion. This represents
a growing figure of approximately 9% of total global pharmaceutical sales.
Priced from $4,950 more information
can be viewed on our online Catalog
To increase your company
profile it is possible to sponsor a future Newsletter or advertise on the
website. Please contact us
to learn more.
DRUG-LIKE SMALL MOLECULES FOR
ChemBridge provides screening
libraries for drug discovery, both combinatorial and hand-synthesized,
compromising over 350,000 small molecules. A proprietary collection of
building blocks is also available. Please see our website for details.
If you can think it, you can build it - develop chemistry software applications
with IDBS Chemical Technologies. Come and see for yourself at the ACS
conference, 18 - 22 August.